Skip navigation

rabies-300x231KATHMANDU, Aug. 30 (Xinhua) — Nepali government is speeding work to introduce tissue-cultured anti-rabies vaccine for humans within two years. Presently the bio-technology is in its trial phase, local media reported on Sunday.

Lat Narayan Chaudhary, assistant zoonotic at Epidemiology and Disease Control Division under the Ministry of Health and Population, said they are sending the second batch of trial vaccines to referral laboratory of the World Health Organization (WHO) to test the quality of the product.

Talking to THT Online, he said the WHO has phased out the betapropiolactone inactivated sheep brain rabies vaccine, which used to be produced here, for human use.

The new technology will save the country 100 million Nepali rupees (some 1.3 million U.S. dollars) annually, which is presently spent on importing anti-rabies vaccine.

Chaudhary claims that the production can meet the domestic demand meeting the standard.



Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: